ArticleClinical drug investigation2023

Cost-Effectiveness Analysis of Atezolizumab versus Platinum-Based Chemotherapy as First-Line Treatment for Patients with Unresectable Advanced Non-small Cell Lung Cancer with PD-L1 Expression Status in Japan.

Yugo Chisaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.